Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 300 of 501 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/31/11
End: 01/31/15
Due: 01/31/16
Phase: N/A
Priority: Normal
Start: 05/31/02
End: 02/29/08
Due: 02/28/09
Phase: N/A
Priority: Normal
Start: 07/31/05
End: 06/30/07
Due: 06/30/08
Phase: N/A
Priority: Normal
Start: 11/30/06
End: 11/30/08
Due: 11/30/09
Phase: N/A
Priority: Normal
Start: 11/30/03
End: 02/29/08
Due: 02/28/09
Phase: N/A
Priority: Normal
Start: 04/04/13
End: 02/18/20
Due: 02/18/21
Phase: N/A
Priority: Normal
Start: 07/31/08
End: 07/31/11
Due: 07/31/12
Phase: N/A
Priority: Normal
Start: 10/31/11
End: 01/31/14
Due: 01/31/15
Phase: N/A
Priority: Normal
Start: 02/28/15
End: 10/31/16
Due: 10/31/17
Phase: N/A
Priority: Normal
Start: 09/30/09
End: 09/30/13
Due: 09/30/14
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/30/12
End: 02/28/15
Due: 02/28/16
Phase: N/A
Priority: Normal
Start: 02/28/05
End: 04/30/11
Due: 04/30/12
Phase: N/A
Priority: Normal
Start: 10/28/13
End: 01/04/18
Due: 01/04/19
Phase: N/A
Priority: Normal
Start: 03/31/08
End: 09/30/11
Due: 09/30/12
Phase: N/A
Priority: Normal
Start: 03/04/19
End: 05/03/24
Due: 05/03/25
Phase: N/A
Priority: Normal
Start: 11/30/12
End: 01/31/15
Due: 01/31/16
Phase: N/A
Priority: Normal
Start: 01/31/08
End: 07/31/10
Due: 07/31/11
Phase: N/A
Priority: Normal
Start: 05/17/17
End: 08/03/19
Due: 08/03/20
Phase: N/A
Priority: Normal
Start: 03/31/07
End: 05/31/08
Due: 05/31/09
Phase: N/A
Priority: Normal
Start: 11/30/04
End: 12/31/08
Due: 12/31/09
Phase: N/A
Priority: Normal
Start: 04/12/18
End: 01/08/21
Due: 01/08/22
Phase: N/A
Priority: Normal
Start: 10/03/18
End: 12/15/21
Due: 12/15/22
Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy
Phase: N/A
Priority: Normal
Start: 06/07/12
End: 02/17/13
Due: 02/17/14
Phase: N/A
Priority: Normal
Start: 01/31/00
End: 12/31/02
Due: 12/31/03